Fox Business - The Power to Prosper
Search Site

Mylan

The little rally that could: What’s boosting the markets?

What’s behind the market rally? FOX Business Contributor Anthony Scaramucci, Former Senior White House Advisor Todd Buchholz and Wells Fargo Chief Portfolio Strategist Brian Jacobsen discuss.

Read More

  1. Market correction coming?

    S&P Capital IQ chief equity strategist Sam Stovall and Wells Fargo Securities senior equity strategist Gina Martin Adams on whether 2014 will be a year of consolidation.

  2. Nasdaq Turns Solidly Higher in Volatile Action

    FOX Business: Capitalism Lives HereThe embattled Nasdaq swung solidly into positive territory in choppy action on Tuesday as traders scooped up beaten-down stocks.To...

  3. Equity Futures Higher Ahead of Monthly Jobs Report

    Stock index futures advanced modestly on Friday, putting the S&P 500 on track to hold near its record high, ahead of the monthly payrolls report.The employment repor...

  4. Mylan May Buy Swedish Pharma Group Meda: WSJ

    Generic drug group Mylan Inc. is mulling the purchase of Swedish pharmaceutical group Meda AB , The Wall Street Journal reported on Friday, citing persons close to t...

  5. Pfizer Loses Ruling On Celebrex Patent Dispute

    Pfizer Inc. on Wednesday announced it lost a patent ruling for its top-selling arthritis drug Celebrex, as the Eastern District Court of Virginia invalidated what is...

  6. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    Shares of Pfizer (NYSE:PFE) fell 1% Wednesday after a U.S. federal court invalidated the reissue patent for its blockbuster osteoarthritis drug Celebrex that would h...

  7. Actavis to buy Forest Labs in $25 billion deal

    Generic drugmaker Actavis Plc said it would acquire specialty pharmaceuticals company Forest Laboratories Inc in a cash and stock deal it valued at about $25 billion...

  8. Wheels Fly Off GM's CEO Pay Story

    Has General Motors' (NYSE:GM) new narrative on chief executive Mary Barra's compensation hit the wall faster than a crash-test dummy?FOX Business has reported as it ...

  9. Mylan Knocked To Equal-weight By Morgan Stanley

    Shares of Mylan Inc. were lowered to equal-weight from overweight on Monday by analysts at Morgan Stanley. While the pharmaceutical company's long-term growth is lik...

  10. Lilly defends blockbuster Alimta with unusual ammo

    Eli Lilly and Co, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds and wins a closely wa...

  11. Perrigo to Buy Ireland's Elan

    U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatm...

  12. Actavis to Buy Warner Chilcott for $5 Billion in Stock

    Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specia...

  1. What to expect this earnings season

    FBN’s Charles Payne, Penn Financial President Matt McCall, Scottie Hughes TPNN.com News Director, CIO A&G Capital Hilary Kramer, Belpointe Asset Management Chief Strategist David Nelson and Needham Growth Fund Co-Portfolio Manager Chris Retzler on stocks winning this earnings season and expectations.

  2. Tony Danza on acting in ‘Honeymoon in Vegas’ on Broadway

    Actor and author Tony Danza discusses his role in ‘Honeymoon in Vegas’ on Broadway.

  3. New Chevy comes with parental controls and driving report card

    ‘The Car Coach’ Lauren Fix on the 2016 Chevy Malibu coming with parental features and a driving report card.

  4. Mylan CEO on generic drug industry, the FDA

    Mylan CEO Heather Bresch discusses the company’s impact on the health care industry, its deal with Abbott Laboratories, future developments and the FDA.

  5. Biggest IPO of the year

    FBN’s Liz MacDonald on GE’s credit unit, Synchrony Financials IPO.

  6. White House calls for ‘economic patriotism’

    FBN’s Lou Dobbs on Obama Administration efforts to discourage U.S. businesses from relocating their headquarters overseas.

  7. $7B shakedown for Citigroup?

    Money Map Press’ Keith Fitz-Gerald, FOX News contributor Guy Benson and FBN’s Nicole Petallides on the markets, Shire, AbbVie, corporate taxes, gold, oil and Citigroup’s settlement with the DOJ.

‹ Prev1234Next ›
Freebase CC-BY
Source: Mylan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL